Guardian Pharmacy Services, Inc. (GRDN) Stock Forecast & Price Target
Guardian Pharmacy Services, Inc. · NYSE
$41.85+0.39 (+0.94%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 5 firms covering Guardian Pharmacy Services, Inc, 5 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $36.00 to $47.00, so the covering firms are broadly aligned. The average target of $43.40 sits 4% above the current $41.85. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.30 next quarter toward $1.36 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 ratings
Moderate Buy
Strong Buy00%
Buy5100%
Hold00%
Sell00%
Strong Sell00%
Based on 5 analysts giving stock ratings to Guardian Pharmacy Services, Inc.
As of Jul, 5 of 5 firms rate GRDN a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
GRDN EPS & revenue forecast
EPS · NEXT QUARTER
$0.30
Range $0.27 – $0.32 · 6 analysts · +21% YoY
Next period, 6 analysts expect Guardian Pharmacy Services, Inc. to earn $0.30 a share (range $0.27 – $0.32), versus $0.25 a year earlier. Full-year consensus is $1.26, growing to $1.36 the year after.
REVENUE · NEXT QUARTER
$358.6M
Range $355.0M – $362.4M · 6 analysts · -5% YoY
Revenue is expected to reach $358.6M (range $355.0M – $362.4M), -5.0% year-over-year. Full-year consensus is $1.4B, rising to $1.5B next year.
Top analysts covering Guardian Pharmacy Services, Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on GRDN.
#1
DM
David Macdonald
Truist Securities · Rank #67
Buy
$47.00+12.3% to target
Overall win rate
51%
+ Follow
#2
Michael Wiederhorn
Oppenheimer
Buy
$43.00+2.7% to target
Coverage
—
+ Follow
#3
Allen Lutz
B of A Securities
Buy
$47.00+12.3% to target
Coverage
—
+ Follow
#4
SF
Scott Fidel
Stephens & Co.
Buy
$36.00-14.0% to target
Coverage
—
+ Follow
#5
RK
Raj Kumar CFA
Stephens
Buy
$36.00-14.0% to target
Coverage
—
+ Follow
GRDN stock forecast FAQ
What is GRDN's average 12-month price target?+
The 5 analysts with a live target average $43.40 for Guardian Pharmacy Services, Inc. over the next 12 months, ranging from a $47.00 high to a $36.00 low.
Is GRDN stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 5 analyst ratings, 5 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for GRDN?+
The Street-high target is $47.00 (Truist Securities), and the Street-low is $36.00 (Stephens & Co.). The average of all 5 active targets is $43.40.
How many Wall Street analysts cover GRDN?+
5 analysts have an active rating on Guardian Pharmacy Services, Inc., and 5 firms carry a live 12-month price target.
Who is the most accurate analyst covering GRDN?+
Among analysts who currently cover GRDN, David Macdonald of Truist Securities has the strongest overall Quantellect track record (Rank #67). Their current call is Buy with a $47.00 target.
What is Guardian Pharmacy Services, Inc.'s projected EPS for next quarter?+
The consensus estimate is $0.30 per share (range $0.27 – $0.32) across 6 analysts. Full-year EPS is projected at $1.26, rising to $1.36 the following year.
How much revenue is Guardian Pharmacy Services, Inc. expected to report next quarter?+
Consensus revenue is $358.6M (range $355.0M – $362.4M). Full-year revenue is projected at $1.4B, growing to $1.5B next year.
Have analysts been upgrading or downgrading GRDN lately?+
As of Jul, 5 of 5 firms rate GRDN a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their GRDN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
